BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18068869)

  • 1. Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
    Cirioni O; Ghiselli R; Kamysz W; Orlando F; Silvestri C; Mocchegiani F; Di Matteo F; Kamysz E; Riva A; Rocchi M; Saba V; Scalise G; Giacometti A
    Peptides; 2008 Jan; 29(1):31-8. PubMed ID: 18068869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Silvestri C; Di Matteo F; Abbruzzetti A; Scalise G; Saba V
    Crit Care Med; 2008 Jan; 36(1):240-5. PubMed ID: 18090372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of citropin 1.1 and tazobactam-piperacillin against oxidative damage and lethality in mice models of gram-negative sepsis.
    Ghiselli R; Silvestri C; Cirioni O; Kamysz W; Orlando F; Calcinari A; Kamysz E; Casteletti S; Rimini M; Tocchini M; Giacometti A; Guerrieri M
    J Surg Res; 2011 Dec; 171(2):726-33. PubMed ID: 20605608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
    Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; D'Amato G; Orlando F; Sisti V; Kamysz W; Silvestri C; Naldoski P; Lukasiak J; Saba V; Scalise G
    J Antimicrob Chemother; 2004 Sep; 54(3):654-60. PubMed ID: 15294887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis.
    Cirioni O; Ghiselli R; Orlando F; Silvestri C; De Luca S; Salzano AM; Mocchegiani F; Saba V; Scalise G; Scaloni A; Giacometti A
    Crit Care Med; 2008 Sep; 36(9):2629-33. PubMed ID: 18679116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide.
    Ghiselli R; Cirioni O; Giacometti A; Mocchegiani F; Orlando F; Bergnach C; Skerlavaj B; Silvestri C; Vittoria AD; Zanetti M; Rocchi M; Scalise G; Saba V
    Peptides; 2006 Nov; 27(11):2592-9. PubMed ID: 16806583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Kamysz W; Rocchi M; D'Amato G; Mocchegiani F; Silvestri C; Łukasiak J; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):207-16. PubMed ID: 15629532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antimicrobial peptide tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model.
    Minardi D; Ghiselli R; Cirioni O; Giacometti A; Kamysz W; Orlando F; Silvestri C; Parri G; Kamysz E; Scalise G; Saba V; Giovanni M
    Peptides; 2007 Dec; 28(12):2293-8. PubMed ID: 18022289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.
    Cirioni O; Ghiselli R; Silvestri C; Kamysz W; Orlando F; Mocchegiani F; Di Matteo F; Riva A; Lukasiak J; Scalise G; Saba V; Giacometti A
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2005-10. PubMed ID: 17403995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis.
    Cirioni O; Wu G; Li L; Orlando F; Silvestri C; Ghiselli R; Shen Z; Scalise A; Gabrielli E; Scuppa D; Romiti C; Provinciali M; Guerrieri M; Giacometti A
    Peptides; 2010 Jul; 31(7):1231-6. PubMed ID: 20381561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection.
    Cirioni O; Silvestri C; Ghiselli R; Orlando F; Riva A; Mocchegiani F; Chiodi L; Castelletti S; Gabrielli E; Saba V; Scalise G; Giacometti A
    J Antimicrob Chemother; 2008 Dec; 62(6):1332-8. PubMed ID: 18799470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis.
    Cirioni O; Ghiselli R; Silvestri C; Kamysz W; Orlando F; Riva A; Kamysz E; Castelletti S; Rocchi M; Saba V; Scalise G; Giacometti A
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4351-5. PubMed ID: 18779356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
    Babalola CP; Nightingale CH; Nicolau DP
    J Antimicrob Chemother; 2004 Jun; 53(6):1098-100. PubMed ID: 15128727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of teicoplanin and G-CSF on survival in experimental MRSA pneumonia in neutropenic mice.
    Oz N; Agalar C; Daphan CE; Agalar F; Turkyilmaz R
    Int J Surg Investig; 2001; 2(5):347-52. PubMed ID: 12678538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of tachyplesin III against Pseudomonas aeruginosa.
    Cirioni O; Giacometti A; Kamysz W; Silvestri C; Riva A; Della Vittoria A; Abbruzzetti A; Lukasiak J; Scalise G
    Peptides; 2007 Apr; 28(4):747-51. PubMed ID: 17331619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor (G-CSF) reduces not only gram-negative but also gram-positive infection-associated proinflammatory cytokine release by interaction between Kupffer cells and leukocytes.
    Busch CJ; Wanner GA; Menger MD; Vollmar B
    Inflamm Res; 2004 May; 53(5):205-10. PubMed ID: 15105970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia.
    Ghiselli R; Giacometti A; Cirioni O; Orlando F; Mocchegiani F; Pacci AM; Scalise G; Saba V
    J Surg Res; 2001 Oct; 100(2):183-8. PubMed ID: 11592790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
    Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Bergnach C; Orlando F; Mocchegiani F; Silvestri C; Skerlavaj B; Licci A; Balaban N; Zanetti M; Scalise G; Saba V
    Shock; 2006 Sep; 26(3):296-301. PubMed ID: 16912656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas aeruginosa.
    Cirioni O; Ghiselli R; Tomasinsig L; Orlando F; Silvestri C; Skerlavaj B; Riva A; Rocchi M; Saba V; Zanetti M; Scalise G; Giacometti A
    Shock; 2008 Oct; 30(4):443-8. PubMed ID: 18391859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.
    Simonetti O; Ganzetti G; Arzeni D; Campanati A; Marconi B; Silvestri C; Cirioni O; Gabrielli E; Lenci I; Kamysz W; Kamysz E; Giacometti A; Scalise G; Barchiesi F; Offidani A
    Peptides; 2009 Oct; 30(10):1794-7. PubMed ID: 19591887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.